Brazilian Society of Hepatology and Brazilian College of Radiology practice guidance for the use of elastography in liver diseases

In 2015 the European Association for the Study of Liver Diseases (EASL) and the Asociaci & oacute;n Latinoamericana para el Estudio del H & iacute;gado (ALEH) published a guideline for the use of non-invasive markers of liver disease. At that time, this guideline focused on the available data regarding ultrasonic-related elastography methods. Since then, much has been published, including new data about XL probe use in transient elastography, magnetic resonance elastography, and non-invasive liver steatosis evaluation. In order to draw evidence-based guidance concerning the use of elastography for non-invasive assessment of fibrosis and steatosis in different chronic liver diseases, the Brazilian Society of Hepatology (SBH) and the Brazilian College of Radiology (CBR) sponsored a single-topic meeting on October 4th, 2019, at S & atilde;o Paulo, Brazil. The aim was to establish specific recommendations regarding the use of imaging-related noninvasive technology to diagnose liver fibrosis and steatosis based on the discussion of evidence-based topics by an organizing committee of experts. It was submitted online to all SBH and CBR members. The present document is the final version of the manuscript that supports the use of this new technology as an alternative to liver biopsy. (c) 2021 Fundaci 6n Cli & acute;nica M & eacute;dica Sur, A.C. Published by Elsevier Espan & tilde;a, S.L.U. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

Automated summary

In 2015, EASL and ALEH published a guideline on the use of non-invasive markers of liver disease, primarily focusing on elastography methods. In 2019, SBH and CBR sponsored a meeting in Brazil to establish specific recommendations on the use of imaging-related noninvasive technology for diagnosing liver fibrosis and steatosis based on evidence-based discussions by an expert committee.